Fennec Pharmaceuticals In... (FENC)
NASDAQ: FENC
· Real-Time Price · USD
7.81
-0.36 (-4.41%)
At close: Jun 17, 2025, 10:42 AM
-4.41% (1D)
| Bid | 7.48 |
| Market Cap | 215.7M |
| Revenue (ttm) | 30.91M |
| Net Income (ttm) | -14.07M |
| EPS (ttm) | -0.53 |
| PE Ratio (ttm) | -14.74 |
| Forward PE | 9.48 |
| Analyst | Strong Buy |
| Ask | 8.16 |
| Volume | 21,299 |
| Avg. Volume (20D) | 89,892 |
| Open | 8.11 |
| Previous Close | 8.17 |
| Day's Range | 7.77 - 8.19 |
| 52-Week Range | 3.96 - 8.72 |
| Beta | 0.40 |
About FENC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol FENC
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for FENC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
-11.19%
Fennec Pharmaceuticals shares are trading lower af...
Unlock content with
Pro Subscription
7 months ago
-11.92%
Fennec Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q3 financial results.
1 month ago · seekingalpha.com
Fennec Pharmaceuticals Inc. (FENC) Q1 2025 Earnings Call TranscriptFennec Pharmaceuticals Inc. (NASDAQ:FENC ) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Robert Andrade - Chief Financial Officer Jeff Hackman - Chief Executive Officer...
